1. The surprising story behind European IPOs

    Interviewee/Contributer: Bernd Muehlenweg

    Organisation: Nanobiotix SA

    Read more

  2. The quest for a cure for Parkinson's disease

    Interviewee/Contributer: Todd Sherer

    Organisation: Michael J Fox Foundation

    Read more

  3. A new venture capital model

    Interviewee/Contributer: Kevin Johnson

    Organisation: Index Ventures Management LLP

    Read more

  4. Interview: 4-Antibody AG - How do you structure a biotech for divestment?

    Interviewee/Contributer: Robert Burns

    Organisation: 4-Antibody AG

    Read more

  5. A Big Pharma deal that shares risk and reward

    Interviewee/Contributer: Bahija Jallal

    Organisation: MedImmune

    Read more

  6. European biotechs rebound sharply

    Interviewee/Contributer: William Ellington

    Organisation: MedNous

    Read more

  7. Due diligence is more than a numbers game

    Interviewee/Contributer: Anthony Sedgwick

    Organisation: Silence Therapeutics Plc

    Read more

  8. The role of technology providers in biotech

    Interviewee/Contributer: John Burt

    Organisation: PolyTherics Ltd

    Read more

  9. Making the most of EU funding

    Interviewee/Contributer: Karen Finn

    Organisation: MedNous

    Read more

  10. $2 billion in new US funding

    Interviewee/Contributer: 

    Organisation: 

    Read more